Molecular Docking and Pharmacokinetic Studies of Moringa oleifera As Angiotensin-Converting Enzyme Inhibitors
Downloads
Background: Hypertension in pregnancy is a vascular disorder that occurs before pregnancy or arises during pregnancy that there were 30% of cases of maternal death. Moringa oleifera's potential to lower blood pressure can be utilized as an alternative antihypertensive during pregnancy, minimizing the risk of preeclampsia. Objective: The purpose of this study was to determine the molecular target of Moringa oleifera is intended to optimize pharmacodynamic activity based on the interaction pattern of the compounds with the ACE inhibitor (PDB ID: 1O86). Methods: Molecular docking is carried out using Autodock 4.0 program (AutoDock Tools). Results: According to the binding energy value and ACE inhibitory interaction, a-Rhamnopyranosyl, b-Sitosterol, and Sinalbin are prospective Moringa oleifera compounds as alternative antihypertensive. These potential compounds can inhibit ACE with binding energy -8.23; -9.27; -9.14 kcal/mol. Pharmacokinetic predictions reported that the potential compounds are absorbed in the intestine and indicates as molecules are tightly bound to plasma proteins and, as well as CYP3A4 and CYP2C9 inhibitors. The prediction of toxicity indicates that the potential compounds are classified as drug-induced acute liver failure with low carcinogens. Conclusion: a-Rhamnopyranosyl, b-Sitosterol and Sinalbin can be suitable lead compounds for synthetic drugs for antihypertensive agents.
Ali, H. A., Al¬Salahi, R., Al¬Asri, J., Mortier, J., & Marzouk, M. (2017). Synthesis, Crystallographic Characterization, Molecular Docking and Biological Activity of Isoquinoline Derivatives. Chemistry Central Journal; 11; 1-14.
Aminah, S., Tezar, R., Muflihani, Y. (2015). Kandungan Nutrisi dan Sifat Fungsional Tanaman Kelor (Moringa oleifera). Buletin Pertanian Perkotaan; 5; 40-53.
Atlas, S. A. (2007). The Renin‑Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition. Journal of Managed Care & Specialty Pharmacy; 13; 9‑20.
Bertilsson, L., Alm, C., De Las Carreras, C., Widen, J., Edman, G., Schalling, D. (1999). Debrisoquine Hydroxylation Polymorphism and Personality. Lancet; 333; 555.
Campbell, N. A. (2002). Biologi Edisi Kelima Jilid 1. Jakarta: Erlangga.
Drie, J. H. (2005). Pharmacophore-based Virtual Screening: a Practical Perspective. Boca Raton: Taylor and Francis Group.
Forli, S., Huey, R., Pique, M. E., Sanner, M. F., Goodsell, D. S., & Olson, A. J. (2016). Computational Protein Ligand Docking and Virtual Drug Screening with the AutoDock Suite. Nature Protocols; 11; 905–919.
Gallo, K., Andrean, G., Preissner, R., & Gohlke, B. O. (2022). SuperPred 3.0: Drug Classification and Target Prediction a Machine Learning Approach. Nucleic Acids Researc; 50; 726-731.
Grinter, S. Z., & Zou, X. (2014). Challenges, Applications, and Recent Advances of Protein-Ligand Docking in Structure-Based Drug Design. Molecules; 19; 10150–10176. doi: 10.3390/molecules190710150.
Hasan, R., Herowati, R., & Widodo, G. P. (2023). Molecular Docking and Pharmacokinetic Prediction of Potential Compounds from Luffa acutangula as Antidiabetic Candidates. Jurnal Pharmacy; 20; 71-76. doi: 10.30595/pharmacy.v0i0.16066.
Helson, H. E. (1999). Structure Diagram Generation. New York: Wiley-VCH.
Hoeltzenbein. (2017). Pregnancy Outcome After First Trimester Use of Methyldopa. Hypertension; 70; 201-208.
Hypercube. (2002). HyperChem Release 7: Tools for Molecular Modeling. Ontorio: Hypercube Inc.
Ideaconsult. (2011). Toxtree User Manual 5th Version. Sofia: Ideaconsult.
Jain, A. N., & Nicholls, A. (2008). Recommendations for Evaluations of Computational Methods. Journal of Computer-Aided Molecular Design; 22: 133-139.
Kario. (2018). Central Sympathetic Agents and Direct Vasodilators in Hypertension: A Companion to Braunwald's Heart Disease (Third Edition) Ch 26. Amsterdam: Elsevier.
Karthikeyan, V. J. (2015). Hypertension in Pregnancy. Oxford: Oxford Cardiology Library.
Krisnadi, D. (2015). Kelor Super Nutrisi. Blora: Pusat Informasi dan Pengembangan Tanaman Kelor Indonesia.
Lipinski, C. A. (2001). Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development. Advanced Drug Delivery Reviews; 46; 3-26.
Malha. (2018). Hypertension in Pregnancy in Hypertension: A Companion to Braunwald's Heart Disease (Third Edition) Ch 39. Amsterdam: Elsevier.
Mengistu, M., Abebe, Y., Mekonnen, Y., & Tolessa, T. (2012). In Vivo and In Vitro Hypotensive Effects of Aqueous Extract of Moringa oleifera. African Health Sciences; 12; 545-551.
Ministry of Health RI. (2013). Basic Health Research 2013. Jakarta: Ministry of Health RI.
Muhammad, S. A., & Fatima, N. (2015). In Silico Analysis and Molecular Docking Studies of Potential Angiotensin-Converting Enzyme Inhibitor using Quercetin Glycosides. Pharmacognosy Magazine; 11; 123–126. doi: 10.4103/0973-1296.157712.
Natesh, R., Schwager, S., Sturrock, E., & Acharya., K. (2003). Crystal Structure of Human Angiotensin Converting Enzyme in complex with lisinopril. Nature; 421; 551–554.
Nathisuwan, S., & Talbert, R. L. (2002). A Review of Vasopeptidase Inhibitors: A New Modality in the Treatment of Hypertension and Chronic Heart Failure. Pharmacotherapy; 22; 27–42. doi: 10.1592/phco.22.1.27.33502.
Olaiya, C. O., Esan, A. M., & Alabi, T. D. (2014). Ameliorative Effects of Sitosterol on Some Biochemical Indices of Hypertension in Wistar Albino Rats. African Journal of Medicine and Medical Sciences; 43; 157-166.
Rachmania, R. A., Supandi, & Christina, F. A. (2016). Analisis Penambatan Molekul Senyawa Flavonoid Buah Mahkota Dewa pada Reseptor α-Glukosidase Sebagai Antidiabetes. Pharmacy; 13; 239-251.
Song, J. C., & White, C. M. (2002). Clinical Pharmacokinetics and Selective Pharmacodynamics of New Angiotensin Converting Enzyme Inhibitors: An Update. Clinical Pharmacology; 41; 207–224. doi: 10.2165/00003088-200241030-00005.
Tjahjono, D. H, & Hamzah, N. (2013). Studi Hubungan Kuantitatif Struktur-Aktivitas, Fitur Farmakofor dan Docking Molekuler Senyawa Turunan Pirazolo-Pirimidin Sebagai Inhibitor Mer Torsin Kinase. Acta Pharmaceutica Indonesia; 38; 1-10.
Van Booven, D., Marsh, S., McLeod, H., Carrillo, M. W., Sangkuhl, K., Klein, T. E., & Altman, R. B. (2010). Cytochrome P450 2C9-CYP2C9. Pharmacogenetics and Genomics; 20; 277–281.
Wati, G. P., Widodo, & Herowati, R. (2020). Prediction of Pharmacokinetics Parameter and Molecular Docking Study of Antidiabetic Compounds from Syzygium polyanthum and Syzygium cumini. Jurnal Kimia Sains dan Aplikasi; 23; 189-195. doi: 10.14710/jksa.23.6.189-195.
Xiangya School of Pharmaceutical Sciences. (2021). ADMETlab 2.0: an Integrated Online Platform for Accurate and Comprehensive Predictions of ADMET Properties. Nucleic Acids Research; 49; 5-14.
Xuan, M., Hong-Xing, Z., Mihaly, M., & Cui, M. (2011) Molecular Docking: a Powerful Approach for Structure-Based Drug Discovery. Current Computer-Aided Drug Design; 7; 146-157. doi: 10.2174/157340911795677602.
Yanti & Nofia. (2020). Pengaruh Pemberian Rebusan Daun Kelor (Moringa oleifera) Terhadap Tekanan Darah Pada Penderita Hipertensi. Jurnal Ilmu Kesehatan; 3; 24-9.
Copyright (c) 2024 JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. The copyright of this journal belongs to the Editorial Board and Journal Manager with the author's knowledge, while the moral right of the publication belong to the author.
2. The formal legal aspect of journal publication accessibility refers to the Creative Commons Attribution-Non-Commercial-Share Alike (CC BY-NC-SA), which implies that the publication can be used for non-commercial purposes in its original form.
3. Every publication (print/electronic) is open access for educational, research, and library purposes. In addition to the objectives mentioned above, the editorial board is not responsible for copyright infringement
.jpg)
